Stemedica Cell Technologies, Inc.
•Download as PPT, PDF•
1 like•327 views
A Harvard study found that treating umbilical cord blood with a molecule called 16, 16-dimethyl prostaglandin E2 (dmPGE2) caused the blood to grow more stem cells faster than untreated cord blood when transplanted into 12 cancer patients. The study successfully helped all patients reconstitute their immune systems. Harvard will now conduct a larger Phase II study involving 60 cancer patients across eight medical centers to further evaluate using dmPGE2 to increase the success of blood stem cell transplants.
Report
Share
Report
Share
Recommended
A Comparative Study on Blood Components Utilization in Selected Hospital-Bloo...
Blood components preparations are undertaken to maximize the potential benefits of the components
present in the whole blood. These blood components are indicated in the treatment of various conditions
including bleeding disorders, trauma, and blood loss due to surgery. A retrospective study on blood
components utilizations of King Khalid Hospital, Maternity Hospital and Hail General Hospital was
conducted. The analysis revealed that King Khalid Hospital has the highest number of utilization for packed
red blood cells, fresh frozen plasma and platelet concentrate. Hail General Hospital has the highest number of
utilization for whole blood. Packed red blood cells is the blood component with the highest utilization among
the three hospital-blood banks. Upgrading of inventory and management of blood and blood components is
essential. Database linkage among the three hospitals on inventory of blood and blood products should be
established to maximize the use of these resources and minimize the wastage.
Convalescent Plasma as a COVID-19 Treatment
I think I can speak for most people when I say that viable treatments and vaccines are desperately needed at this point to overcome the COVID-19 global pandemic. Not only that COVID-19 has taken so many lives across the globe, the societal, public health and financial ramifications will be with us for years to come...
Stem Cell Transplants
Based in San Diego, California, Stemedica is an international biopharmaceutical company that focuses on the development, manufacture and distribution of allogeneic stem cell technology. Stemedica manufactures its ischemia-tolerant stem cells in a licensed cGMP-compliant facility, and its stem cells are only used in studies approved by the FDA and other national regulatory agency in countries where Stemedica’s product is being advanced via clinical trials.
Stemedica Cell Technologies’ Subsidiary Starts Stem Cell Trials
A respected biotechnology company, Stemedica Cell Technologies, Inc., remains at the forefront of regenerative medicine through innovations in stem cells and biological compounds. Additionally, Stemedica Cell Technologies produces some of these advancements through its recently formed cardiology subsidiary named CardioCell LLC.
Jdd machine learning
How to use text data to draw conclusions about users of our website or forum?
This talk describes a solution to a particular problem, using Machine Learning and Statistics. Based on provided forum we will create the program that learns the structure of posts using Natural Language Processing technics. Then after proper Machine Learning models are trained, program is able to answer with probability which of the users of the forum wrote a particular post.
We will go through all the steps required to create Machine Learning models for text. How to use Natural Language Processing and Bag-of-Words techniques to analyse text? How to prepare input data to further Processing by Machine Learning Models? I will answer those questions. Implementation will be written in Apache Spark, so we will get to know that technology with some important libraries like Spark MLlib and DataFrame API. In MLlib we will use Gaussian Mixure Model and Logistic Regression.
Recommended
A Comparative Study on Blood Components Utilization in Selected Hospital-Bloo...
Blood components preparations are undertaken to maximize the potential benefits of the components
present in the whole blood. These blood components are indicated in the treatment of various conditions
including bleeding disorders, trauma, and blood loss due to surgery. A retrospective study on blood
components utilizations of King Khalid Hospital, Maternity Hospital and Hail General Hospital was
conducted. The analysis revealed that King Khalid Hospital has the highest number of utilization for packed
red blood cells, fresh frozen plasma and platelet concentrate. Hail General Hospital has the highest number of
utilization for whole blood. Packed red blood cells is the blood component with the highest utilization among
the three hospital-blood banks. Upgrading of inventory and management of blood and blood components is
essential. Database linkage among the three hospitals on inventory of blood and blood products should be
established to maximize the use of these resources and minimize the wastage.
Convalescent Plasma as a COVID-19 Treatment
I think I can speak for most people when I say that viable treatments and vaccines are desperately needed at this point to overcome the COVID-19 global pandemic. Not only that COVID-19 has taken so many lives across the globe, the societal, public health and financial ramifications will be with us for years to come...
Stem Cell Transplants
Based in San Diego, California, Stemedica is an international biopharmaceutical company that focuses on the development, manufacture and distribution of allogeneic stem cell technology. Stemedica manufactures its ischemia-tolerant stem cells in a licensed cGMP-compliant facility, and its stem cells are only used in studies approved by the FDA and other national regulatory agency in countries where Stemedica’s product is being advanced via clinical trials.
Stemedica Cell Technologies’ Subsidiary Starts Stem Cell Trials
A respected biotechnology company, Stemedica Cell Technologies, Inc., remains at the forefront of regenerative medicine through innovations in stem cells and biological compounds. Additionally, Stemedica Cell Technologies produces some of these advancements through its recently formed cardiology subsidiary named CardioCell LLC.
Jdd machine learning
How to use text data to draw conclusions about users of our website or forum?
This talk describes a solution to a particular problem, using Machine Learning and Statistics. Based on provided forum we will create the program that learns the structure of posts using Natural Language Processing technics. Then after proper Machine Learning models are trained, program is able to answer with probability which of the users of the forum wrote a particular post.
We will go through all the steps required to create Machine Learning models for text. How to use Natural Language Processing and Bag-of-Words techniques to analyse text? How to prepare input data to further Processing by Machine Learning Models? I will answer those questions. Implementation will be written in Apache Spark, so we will get to know that technology with some important libraries like Spark MLlib and DataFrame API. In MLlib we will use Gaussian Mixure Model and Logistic Regression.
compendium-second-edition-may-2011-Dr-Zia
This is Second Edition of Compendium of selected cases for the
educational purposes of the medical
technologists, residents in pathology,
pathologists, oncologists, and clinical
chemists
CMMRF Catch the Vision
The Cryptic Masons Medical Research Foundation and their work at the University of Indiana School of Medicine in Indianapolis
From Bench to Business
Canada is a hotbed for the commercialization of regenerative medicine and stem cell discoveries. How appropriate, since two Canadian doctors, James Till and Ernest McCulloch discovered transplantable stem cells at the Ontario Cancer Institute in Toronto in 1961.
Accelerated growth in this industry sector is opening up new job opportunities for medical laboratory technologists. The benefits include working with scientific discoveries and leading-edge technologies to find exciting new treatment options that can help people living with devastating diseases and conditions.
Check out my story From Bench to Business in the Winter 2015 issue of the Canadian Journal of Medical Laboratory Science. I enjoyed interviewing Lianne Witt, technical director of laboratory and client services at Insception Lifebank, Canada’s largest private cord blood bank, and Emily Titus, manager of technology at Centre for Commercialization for Regenerative Medicine (CCRM). Their career paths are inspiring for medical laboratory technologists looking for opportunities beyond traditional hospital labs. It is a great time to be working in the fields of regenerative medicine and stem cells!
09 CeoMeeting- Session 4- Artisan
Session 4: Health & Wellness
Title: The Changing Face Of Healthcare: Where Are The Opportunities?
Dr Jeff Wager, Artisan Pharma
Estudio Xatoa
Les comparto la publicación del estudio Xatoa
Nosotros en la Clínica de Mérida participamos como investigadores en el reclutamiento y análisis de datos de los pacientes de nuestra consulta diaria quienes han recibido el beneficio de la Terapia de Inhibición de Doble Vía.
Es un gusto enorme contribuir al desarrollo del conocimiento médico global 🌎
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-Farber
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-FarberDana-Farber Cancer Institute
A behind-the-scenes look at Dana-Farber Cancer Institute, as seen through the eyes of our patients, doctors, nurses, researchers, staff, and volunteers. and Two Case Stories with Infective Episodes in Pacemaker Treated Patients.pdf
Essay Writing Service
http://StudyHub.vip/And---Two-Case-Stories-With-Infective-E
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...UC San Diego AntiViral Research Center
Joseph Eron, M.D., of University of North Carolina at Chapel Hill, presents "The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean for Patients" at AIDS Clinical RoundsBio Pharmic2
Project Management: Regulatory Affairs and Clinical Trials Class Presentation - Round 2 of Prodcut Development
Cellular & Gene Therapy
These slides discusses on cellular and gene therapy: the use of cells and genes to treat disease. These therapies can be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several types of cancers.
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Join Monopoly Pharma PCD Franchise in Jharkhand :Ranchi, Jamshedpur, Dhanbad, Bokaro Steel City, Hazaribagh, Deoghar, Giridih, etc.
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
More Related Content
Similar to Stemedica Cell Technologies, Inc.
compendium-second-edition-may-2011-Dr-Zia
This is Second Edition of Compendium of selected cases for the
educational purposes of the medical
technologists, residents in pathology,
pathologists, oncologists, and clinical
chemists
CMMRF Catch the Vision
The Cryptic Masons Medical Research Foundation and their work at the University of Indiana School of Medicine in Indianapolis
From Bench to Business
Canada is a hotbed for the commercialization of regenerative medicine and stem cell discoveries. How appropriate, since two Canadian doctors, James Till and Ernest McCulloch discovered transplantable stem cells at the Ontario Cancer Institute in Toronto in 1961.
Accelerated growth in this industry sector is opening up new job opportunities for medical laboratory technologists. The benefits include working with scientific discoveries and leading-edge technologies to find exciting new treatment options that can help people living with devastating diseases and conditions.
Check out my story From Bench to Business in the Winter 2015 issue of the Canadian Journal of Medical Laboratory Science. I enjoyed interviewing Lianne Witt, technical director of laboratory and client services at Insception Lifebank, Canada’s largest private cord blood bank, and Emily Titus, manager of technology at Centre for Commercialization for Regenerative Medicine (CCRM). Their career paths are inspiring for medical laboratory technologists looking for opportunities beyond traditional hospital labs. It is a great time to be working in the fields of regenerative medicine and stem cells!
09 CeoMeeting- Session 4- Artisan
Session 4: Health & Wellness
Title: The Changing Face Of Healthcare: Where Are The Opportunities?
Dr Jeff Wager, Artisan Pharma
Estudio Xatoa
Les comparto la publicación del estudio Xatoa
Nosotros en la Clínica de Mérida participamos como investigadores en el reclutamiento y análisis de datos de los pacientes de nuestra consulta diaria quienes han recibido el beneficio de la Terapia de Inhibición de Doble Vía.
Es un gusto enorme contribuir al desarrollo del conocimiento médico global 🌎
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-Farber
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-FarberDana-Farber Cancer Institute
A behind-the-scenes look at Dana-Farber Cancer Institute, as seen through the eyes of our patients, doctors, nurses, researchers, staff, and volunteers. and Two Case Stories with Infective Episodes in Pacemaker Treated Patients.pdf
Essay Writing Service
http://StudyHub.vip/And---Two-Case-Stories-With-Infective-E
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...UC San Diego AntiViral Research Center
Joseph Eron, M.D., of University of North Carolina at Chapel Hill, presents "The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean for Patients" at AIDS Clinical RoundsBio Pharmic2
Project Management: Regulatory Affairs and Clinical Trials Class Presentation - Round 2 of Prodcut Development
Cellular & Gene Therapy
These slides discusses on cellular and gene therapy: the use of cells and genes to treat disease. These therapies can be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several types of cancers.
Similar to Stemedica Cell Technologies, Inc. (20)
Drazen transparency for clinical trials -- the test act
Drazen transparency for clinical trials -- the test act
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-Farber
Photos We Love: Behind the Scenes of Inspiration and Discovery at Dana-Farber
and Two Case Stories with Infective Episodes in Pacemaker Treated Patients.pdf
and Two Case Stories with Infective Episodes in Pacemaker Treated Patients.pdf
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
Recently uploaded
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Join Monopoly Pharma PCD Franchise in Jharkhand :Ranchi, Jamshedpur, Dhanbad, Bokaro Steel City, Hazaribagh, Deoghar, Giridih, etc.
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With 100% Satisfaction
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Are There Any Natural Remedies To Treat Syphilis.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnataka
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recently uploaded (20)
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Stemedica Cell Technologies, Inc.
- 1. Harvard Study Identifies Molecule That Boosts Stem Cell Growth
- 2. San Diego-based biotechnology firm Stemedica Cell Technologies, Inc., manufactures allogeneic stem cells used in pre-clinical and clinical trial studies held at accredited hospitals and major research institutions. Stemedica’s ischemic-tolerant stem cells support research initiatives worldwide, including the firm’s own Phase II clinical studies for acute ischemic stroke, cutaneous photo aging and acute myocardial infarction.
- 3. The use of stem cells continues to produce medical innovations. Recently, the Harvard Stem Cell Institute published results from its first-ever clinical trials indicating that a specific molecule could increase the success rate of blood stem cell transplantations in cancer patients. In Phase IB of the institute’s study, researchers found that umbilical cord blood treated with a molecule derived from fatty acids known as 16, 16-dimethyl prostaglandin E2 (or dmPGE2) grew more stem cells faster than the use of untreated umbilical cord blood.
- 4. The Harvard study included 12 participants, each undergoing umbilical cord blood transplantation therapy for either leukemia or lymphoma at Massachusetts General Hospital and the Dana-Farber Cancer Institute. All 12 patients received two blood units, one treated with dmPGE2 and the other untreated, and all 12 patients achieved immune system reconstitution. The Harvard study will now enter Phase II, which will involve some 60 cancer patients at eight different medical centers.